BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 27879397)

  • 1. "All That Necroses Is Not Toxic Epidermal Necrolysis".
    Razmi T M; Shivaprakash MR; Saikia UN; De D; Handa S
    J Cutan Med Surg; 2017; 21(2):172-173. PubMed ID: 27879397
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of carbamazepine and lamotrigine in a Taiwanese diabetic patient with bipolar disorder.
    Chao KC; Lu ML; Shen WW
    Psychiatry Clin Neurosci; 2012 Oct; 66(6):538-9. PubMed ID: 23066779
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravenous immunoglobulins for delayed wound healing associated with toxic epidermal necrolysis.
    Dequidt L; Darrigade AS; Camus T; Taieb A; Milpied B
    Eur J Dermatol; 2019 Apr; 29(2):229-231. PubMed ID: 30983592
    [No Abstract]   [Full Text] [Related]  

  • 4. Intravenous immune globulin therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis complicated by hemolysis leading to pigment nephropathy and hemodialysis.
    Ririe MR; Blaylock RC; Morris SE; Jung JY
    J Am Acad Dermatol; 2013 Aug; 69(2):221-5. PubMed ID: 23673282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stevens-Johnson syndrome and toxic epidermal necrolysis: a report of six cases.
    Kara A; Devrim İ; Çağlar İ; Bayram N; Kundak S; Apa H; Altan EV
    Turk J Pediatr; 2019; 61(4):538-543. PubMed ID: 31990471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between carbamazepine and valproate and adverse cutaneous drug reactions in patients with bipolar disorder: a nested matched case-control study.
    Gau SS; Chao PF; Lin YJ; Chang CJ; Gau CS
    J Clin Psychopharmacol; 2008 Oct; 28(5):509-17. PubMed ID: 18794645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
    Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR
    Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of intravenous immunoglobulin for Stevens-Johnson syndrome and toxic epidermal necrolysis in children: Report of two cases secondary to anticonvulsants.
    Romero-Tapia SJ; Cámara-Combaluzier HH; Baeza-Bacab MA; Cerino-Javier R; Bulnes-Mendizabal DP; Virgen-Ortega C
    Allergol Immunopathol (Madr); 2015; 43(2):227-9. PubMed ID: 25183634
    [No Abstract]   [Full Text] [Related]  

  • 9. Practical considerations for carbamazepine use in bipolar disorder.
    Fuller MA; Dostrow V; Gupta S; Gazda TD
    Expert Opin Drug Saf; 2006 Jul; 5(4):501-9. PubMed ID: 16774489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of intravenous immunoglobulin in toxic epidermal necrolysis and Stevens-Johnson syndrome].
    Kühn-Córdova I; Ramírez-Bouchan D; Gamboa-Marrufo JD
    An Pediatr (Barc); 2007 Jul; 67(1):68-73. PubMed ID: 17663910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A poisoned bouquet from Peru.
    Vermorel A; Issa N; Gabriel F; Accoceberry I; Valenzuela G; Darrigade AS; Camou F
    Clin Microbiol Infect; 2019 Dec; 25(12):1517-1518. PubMed ID: 31442609
    [No Abstract]   [Full Text] [Related]  

  • 12. Heparin-induced thrombocytopenia in a nonthrombocytopenic patient with toxic epidermal necrolysis causing fatal outcome: is HIT still a HIT?
    Busche MN; Peters T; Knobloch K; Vogt PM; Rennekampff HO
    J Burn Care Res; 2009; 30(4):747-51. PubMed ID: 19506511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxic epidermal necrolysis complicated by delayed mucosal healing and haemorrhagic mucositis.
    Dawe S; Bentley R; Creamer D
    Clin Exp Dermatol; 2003 Jul; 28(4):454-5. PubMed ID: 12823319
    [No Abstract]   [Full Text] [Related]  

  • 14. Stevens-Johnson syndrome and toxic epidermal necrolysis in children.
    Atanasković-Marković M; Medjo B; Gavrović-Jankulović M; Ćirković Veličković T; Nikolić D; Nestorović B
    Pediatr Allergy Immunol; 2013 Nov; 24(7):645-9. PubMed ID: 24028417
    [No Abstract]   [Full Text] [Related]  

  • 15. [Stevens-Johnson syndrome and toxic epidermal necrolysis].
    Kaur-Knudsen D; Zachariae C; Thomsen SF
    Ugeskr Laeger; 2013 Dec; 175(50):3096-9. PubMed ID: 24629532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxychloroquine-induced fatal toxic epidermal necrolysis complicated by angioinvasive rhizopus.
    Cameron MC; Word AP; Dominguez A
    Dermatol Online J; 2014 Nov; 20(11):. PubMed ID: 25419748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Toxic epidermal necrolysis treated with intravenous immunoglobulins].
    Corne P; Dereure O; Guilhou JJ; Jonquet O
    Rev Med Interne; 2001 May; 22(5):491-2. PubMed ID: 11402525
    [No Abstract]   [Full Text] [Related]  

  • 18. Rhabdomyolysis as a potential complication of carbamazepine-induced toxic epidermal necrolysis.
    Huang LY; Lin CM; Chiou CC; Lin WS; Cheng SM
    Clin Biochem; 2012 Nov; 45(16-17):1531-2. PubMed ID: 22728955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe cutaneous adverse reactions: acute generalized exanthematous pustulosis, toxic epidermal necrolysis and Stevens-Johnson syndrome.
    Harr T; French LE
    Med Clin North Am; 2010 Jul; 94(4):727-42, x. PubMed ID: 20609860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluconazole-carbamazepine interaction in a patient with bipolar disorder.
    Tsouli S; Maranis S; Kyritsis AP
    Psychiatry Clin Neurosci; 2011 Feb; 65(1):112. PubMed ID: 21265947
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.